Nrx Pharmaceuticals, INC. (NRXPW) — DEF 14A Filings

All DEF 14A filings from Nrx Pharmaceuticals, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

NRX Pharmaceuticals Files 2024 Proxy Statement — Sep 5, 2024 Risk: low
NRX Pharmaceuticals, Inc. filed a DEF 14A on September 5, 2024, for its annual meeting on October 8, 2024. The company, formerly known as Big Rock Partners Acqu
NRX Pharmaceuticals to Hold Special Meeting of Stockholders on March 21, 2024 — Mar 11, 2024 Risk: low
NRX Pharmaceuticals, Inc. (NRXPW) filed a Proxy Statement (DEF 14A) with the SEC on March 11, 2024. NRX Pharmaceuticals will hold a special meeting of stockhold

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX